Ergoteles’s ICU Medical ICUI Stock Holding History

Ergoteles’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,096	Closed	-$1.59M	–	1475
2022 Q4	$1.59M	Buy	+10,096	New	+$1.54M	0.06%	332
2021 Q3	–	Sell	-1,100	Closed	-$226K	–	1421
2021 Q2	$226K	Buy	+1,100	New	+$226K	0.01%	1214
2021 Q1	–	Sell	-1,400	Closed	-$300K	–	917
2020 Q4	$300K	Sell	1,400 -925	-40%	-$179K	0.01%	527
2020 Q3	$425K	Buy	+2,325	New	+$438K	0.06%	267

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Ergoteles's ICUI Position: Q1 2023 in Review

Ergoteles sold out of ICU Medical (ICUI) in Q1 2023, closing a stake of 10,096 shares — an estimated $1.59M sold.

Ergoteles first reported a position in ICUI in Q3 2020 and held it in 4 quarters. The position peaked at $1.59M in Q4 2022. 232 funds tracked by Wall St. Rank hold ICUI as of Q1 2023.

Ergoteles reported no remaining ICU Medical position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 10,096 ICU Medical shares in Q1 2023, an estimated $1.59M.
Ergoteles first reported a position in ICU Medical in Q3 2020 and held it in 4 quarters.
Ergoteles's ICU Medical position peaked at $1.59M in Q4 2022.
232 funds tracked by Wall St. Rank held ICU Medical as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.